Alafi Christopher D
Insider CIK 1299430 · STXS Director, 10% owner · ITCI Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITCI Intra-Cellular Therapies, | S Sale | 2021-05-28 | 2021-05-28 | 38,843 | $40.12 | $1.56M | 95,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-05-27 | 2021-05-28 | 8,482 | $40.01 | $339.4K | 133,843 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-05-24 | 2021-05-25 | 26,575 | $40.47 | $1.08M | 142,325 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-05-21 | 2021-05-25 | 1,100 | $40.00 | $44.0K | 168,900 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2021-03-31 | 2021-04-02 | 464 | $33.93 | $15.7K | 346,795 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-12-31 | 2021-01-05 | 495 | $31.80 | $15.7K | 346,331 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-09-30 | 2020-10-02 | 613 | $25.66 | $15.7K | 345,836 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2020-09-14 | 2020-09-14 | 49,500 | $29.60 | $1.47M | 4,743,770 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2020-09-11 | 2020-09-11 | 21,000 | $28.08 | $589.7K | 4,694,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-06-30 | 2020-07-02 | 613 | $25.67 | $15.7K | 345,223 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-05-27 | 2020-05-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-03-31 | 2020-04-02 | 1,024 | $15.37 | $15.7K | 344,610 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-12-31 | 2020-01-03 | 422 | $34.31 | $14.5K | 343,586 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-09-30 | 2019-10-02 | 1,941 | $7.47 | $14.5K | 343,164 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-09-10 | 2019-09-11 | 320,095 | $10.58 | $3.39M | 4,667,030 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-09-10 | 2019-09-11 | 155,116 | $9.59 | $1.49M | 4,346,935 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-09-10 | 2019-09-11 | 6,240 | $11.00 | $68.6K | 4,673,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-09-10 | 2019-09-11 | 3,549 | $8.98 | $31.9K | 4,191,819 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-08-30 | 2019-09-04 | 125,000 | $8.52 | $1.06M | 4,188,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-06-28 | 2019-07-02 | 1,117 | $12.98 | $14.5K | 341,223 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-06-25 | 2019-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | G Gift | 2019-06-17 | 2019-06-19 | 400,000 | — | $0 | 340,106 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-06-12 | 2019-06-14 | 58,705 | $12.00 | $704.5K | 170,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-06-12 | 2019-06-14 | 16,226 | $10.91 | $177.0K | 16,226 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-06-12 | 2019-06-14 | 95,069 | $11.70 | $1.11M | 111,295 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2019-05-14 | 2019-05-15 | 100,000 | $12.56 | $1.26M | 4,053,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-03-31 | 2019-04-02 | 1,190 | $12.18 | $14.5K | 750,106 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-12-31 | 2019-01-03 | 1,273 | $11.39 | $14.5K | 748,916 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-09-30 | 2018-10-02 | 668 | $21.70 | $14.5K | 747,643 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-06-29 | 2018-07-03 | 820 | $17.67 | $14.5K | 746,975 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-06-18 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-03-30 | 2018-04-03 | 688 | $21.05 | $14.5K | 746,155 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2017-12-29 | 2018-01-03 | 1,001 | $14.48 | $14.5K | 745,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-12-29 | 2018-01-03 | 1,001 | $14.48 | $14.5K | 745,467 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2017-11-22 | 2019-06-19 | 10,000 | $15.55 | $155.5K | 3,963,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2017-11-22 | 2017-11-27 | 10,000 | $15.55 | $155.5K | 744,466 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2017-10-02 | 2017-10-03 | 258,065 | $15.50 | $4.00M | 3,953,270 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-09-29 | 2017-10-03 | 918 | — | $0 | 734,466 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-06-30 | 2017-07-05 | 1,167 | — | $0 | 733,548 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-06-27 | 2017-06-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-03-31 | 2017-04-04 | 892 | — | $0 | 732,381 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-12-30 | 2017-01-03 | 960 | — | $0 | 731,489 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2016-12-07 | 2016-12-07 | 20,826 | $16.14 | $336.1K | 3,695,205 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2016-12-06 | 2016-12-07 | 44,174 | $16.33 | $721.4K | 3,674,379 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2016-11-14 | 2016-11-17 | 34,000 | $14.50 | $493.0K | 3,630,205 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-09-30 | 2016-10-04 | 951 | — | $0 | 730,529 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-06-30 | 2016-07-05 | 373 | — | $0 | 729,578 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-06-14 | 2016-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-03-31 | 2016-04-04 | 377 | — | $0 | 729,205 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2016-02-29 | 2016-02-29 | 100,000 | $29.70 | $2.97M | 728,828 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-12-31 | 2016-01-05 | 195 | $53.79 | $10.5K | 628,828 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-09-30 | 2015-10-02 | 262 | — | $0 | 628,633 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-06-30 | 2015-07-02 | 328 | — | $0 | 628,371 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2015-06-16 | 2015-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-03-31 | 2015-04-02 | 439 | — | $0 | 628,043 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2015-03-11 | 2015-03-12 | 625,000 | $24.00 | $15.00M | 627,604 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-12-31 | 2015-01-05 | 594 | — | $0 | 2,604 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-12-01 | 2014-12-03 | 1,422 | $14.75 | $21.0K | 3,596,205 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-28 | 2014-11-28 | 35,000 | $14.75 | $516.3K | 3,594,783 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-19 | 2014-11-21 | 1,034 | $14.25 | $14.7K | 3,559,783 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-18 | 2014-11-18 | 3,531 | $14.23 | $50.2K | 3,558,749 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-14 | 2014-11-18 | 133 | $15.07 | $2.0K | 3,555,218 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-13 | 2014-11-13 | 2,200 | $15.12 | $33.3K | 3,555,085 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-12 | 2014-11-13 | 5,000 | $15.23 | $76.2K | 3,552,885 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-11 | 2014-11-13 | 5,000 | $15.55 | $77.8K | 3,547,885 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-09-30 | 2014-10-02 | 765 | — | $0 | 2,010 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2014-06-30 | 2014-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-06-30 | 2014-07-02 | 1,245 | — | $0 | 1,245 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-20 | 2013-08-20 | 22,220 | $3.70 | $82.2K | 1,266,628 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-19 | 2013-08-20 | 239,021 | $3.74 | $893.9K | 1,288,848 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-16 | 2013-08-20 | 261,241 | $3.36 | $877.8K | 606,249 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-16 | 2013-08-20 | 261,241 | $3.36 | $877.8K | 1,527,869 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2013-07-31 | 2013-08-15 | 4,771 | — | $0 | 4,771 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2013-06-28 | 2013-08-15 | 16,129 | — | $0 | 16,129 | SEC↗ |
| STXS Stereotaxis, Inc. | P Buy deriv | 2012-05-10 | 2012-05-14 | 8,674,908 | — | $0 | 8,674,908 | SEC↗ |
| STXS Stereotaxis, Inc. | P Buy | 2012-05-10 | 2012-05-14 | 8,674,908 | — | $0 | 12,666,281 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2012-05-07 | 2012-05-14 | 781,018 | — | $0 | 781,018 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2012-05-01 | 2012-05-03 | 304,878 | — | $0 | 304,878 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2012-03-30 | 2012-04-03 | 378,673 | — | $0 | 378,673 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2012-01-03 | 2012-01-05 | 17,647 | — | $0 | 245,933 | SEC↗ |